openPR Logo
Press release

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019 | Astellas Pharma Inc, AstraZeneca Plc, Biogen Inc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co, Cadent Therapeutics Inc, Coronis NeuroSciences Ltd, Eli Lilly and

02-12-2019 08:31 AM CET | Health & Medicine

Press release from: reports intellect

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019, provides an overview of the Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline landscape.

Cognitive functioning is moderately to severely impair in patients with schizophrenia. Symptoms include poor executive functioning, inability to sustain attention and problems with working memory. Predisposing factors include family history, age and autoimmune diseases. Treatment includes antipsychotic medications.

Get Sample Copy of this Report@ https://bit.ly/2UWhjTD

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Cognitive Impairment Associated With Schizophrenia (CIAS) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II, Phase I, Preclinical and Discovery stages are 9, 5, 11 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Companies Mentioned @ Astellas Pharma Inc, AstraZeneca Plc, Biogen Inc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co, Cadent Therapeutics Inc, Coronis NeuroSciences Ltd, Eli Lilly and Co, F. Hoffmann-La Roche Ltd, Iproteos SL, Pfizer Inc, SK Biopharmaceuticals Co Ltd, Sosei Heptares, Spherium Biomed SL, Takeda Pharmaceutical Co Ltd, Vanda Pharmaceuticals Inc

Get the best Discount in the market here @ https://bit.ly/2BvveJ5

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System).
- The pipeline guide reviews pipeline therapeutics for Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Cognitive Impairment Associated With Schizophrenia (CIAS) (Central Nervous System)

About Us:

Reports Intellect is your one-stop solution for everything related to market research and market intelligence. We understand the importance of market intelligence and its need in today's competitive world.

Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you.

So whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

Contact Us:

sales@reportsintellect.com
PH - + 1-888-259-6883
US Address:
225 Peachtree Street NE,
Suite 400,
Atlanta, GA 30303

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Review, H1 2019 | Astellas Pharma Inc, AstraZeneca Plc, Biogen Inc, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Co, Cadent Therapeutics Inc, Coronis NeuroSciences Ltd, Eli Lilly and here

News-ID: 1579512 • Views:

More Releases from reports intellect

Global Golf Cart Market 2025 by Manufacturers, Regions, Type and Application, Fo …
Golf Cart Market Research report evaluates the global Golf Cart market landscape and provides a comprehensive yet in detailed assessment of the market scope. The report provides a thorough business analysis of the major players in the Golf Cart market. The report offers an all-inclusive detailed account of the global trends and scope of the Golf Cart market. The report comprises of data that will be crucial to ensure a
Hair Mask Market 2025 by Manufacturers, Regions, Type and Application, Forecast …
Hair Mask Market Research report evaluates the global Hair Mask market landscape and provides a comprehensive yet in detailed assessment of the market scope. The report provides a thorough business analysis of the major players in the Hair Mask market. The report offers an all-inclusive detailed account of the global trends and scope of the Hair Mask market. The report comprises of data that will be crucial to ensure a
Steel Market Size, Share, Latest Trends, Detailed Forecast Report 2025-2035
Steel Market Research report evaluates the global Steel market landscape and provides a comprehensive yet in detailed assessment of the market scope. The report provides a thorough business analysis of the major players in the Steel market. The report offers an all-inclusive detailed account of the global trends and scope of the Steel market. The report comprises of data that will be crucial to ensure a good growth curve along
Global Costume Jewelry Market Insights, Forecast 2025 to 2035
Costume Jewelry Market Research report evaluates the global Costume Jewelry market landscape and provides a comprehensive yet in detailed assessment of the market scope. The report provides a thorough business analysis of the major players in the Costume Jewelry market. The report offers an all-inclusive detailed account of the global trends and scope of the Costume Jewelry market. The report comprises of data that will be crucial to ensure a

All 5 Releases


More Releases for Cognitive

Internet User Surge Fuels Cognitive Media Market Growth Despite Cognitive Concer …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Cognitive Media Industry Market Size Be by 2025? The size of the cognitive media market has experienced significant expansion lately. It is forecasted to increase from $2.14 billion in 2024 to $2.67 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.8%. The historic
Cognitive Suites
Introducing cutting-edge technology-driven solutions and smart software applications tailor-made for diverse aviation stakeholders. Our comprehensive suite covers Airlines, General Aviation, Aviation Support Service Providers, Aviation Professionals, and Authorities of Airports and Air Navigation Service Providers (ANSP). Whether you're seeking enhanced operational efficiency, streamlined processes, or advanced data analytics, our solutions are designed to revolutionize the way you navigate the skies. Embrace the power of innovation and elevate your aviation experience
The Future of Cognitive Intelligence: Analyzing the Booming Cognitive Computing …
Cognitive Computing Market Valued at 𝐔𝐒$ 𝟒𝟔.𝟓𝟒 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 in 2024, Projected to Reach US$ 285.72 Billion by 2033 at a CAGR of 22.30% The cognitive computing market is witnessing unprecedented growth as industries integrate artificial intelligence (AI), machine learning (ML), natural language processing (NLP), and deep learning into their operations. These next-generation computing systems simulate human thought processes, allowing enterprises to analyze vast datasets, enhance decision-making, and optimize automation at an
Cognitive Search Tools Market: Know Opportunity Ahead | Sinequa, Lucidworks, Cog …
HTF MI recently introduced Global Cognitive Search Tools Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Some key players from the complete study Microsoft Corporation, IBM, Google, Amazon Web Services (AWS), Dassault Systèmes, Verint Systems, Elastic,
Cognitive Services Market
With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. While preparing this Cognitive Services Market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. Every possible effort has been taken while researching and analysing information to
Cognitive Computing Market worth Observing Growth: Saffron Technology, Cognitive …
Cognitive computing is an evolving model of intelligent computing system and methods that implements computational intelligence by autonomous perceptions and inferences imitating the mechanisms of the brain. The cognitive computing market has high growth prospects owing to increasingly complex and large datasets and the emergence of numerous computing platforms such as big data analytics, cloud, and mobile. Moreover, increasing demand from the end-use industries expected to fuel market growth during